Details
Structure visualisation
Entry information
| Complex | |
| AACDB_ID: | 3449 |
| PDBID: | 7CGW |
| Chains: | HL_P |
| Organism: | Homo sapiens |
| Method: | XRD |
| Resolution (Å): | 3.20 |
| Reference: | 10.1002/2211-5463.13102 |
| Antibody | |
| Antibody: | tislelizumab Fab |
| Antibody mutation: | No |
| INN (Clinical Trial): | Tislelizumab(Approved) |
| Antigen | |
| Antigen: | Programmed cell death protein 1(PD-1) |
| Antigen mutation: | No |
| Durg Target: | Q15116 |
Sequence information
Antibody
Heavy Chain: H
Mutation: NULL
| >7CGW_H|Chain A, D[auth H]|Heavy chain of tislelizumab Fab|Homo sapiens (9606) QVQLQESGPGLVKPSETLSLTCTVSGFSLTSYGVHWIRQPPGKGLEWIGVIYADGSTNYNPSLKSRVTISKDTSKNQVSLKLSSVTAADTAVYYCARAYGNYWYIDVWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYGPHHHHHH |
Light Chain: L
Mutation: NULL
| >7CGW_L|Chain B, E[auth L]|Light chain of tislelizumab Fab|Homo sapiens (9606) DIVMTQSPDSLAVSLGERATINCKSSESVSNDVAWYQQKPGQPPKLLINYAFHRFTGVPDRFSGSGYGTDFTLTISSLQAEDVAVYYCHQAYSSPYTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC |
Antigen
Chain: P
Mutation: NULL
| >7CGW_P|Chain C, F[auth P]|Programmed cell death protein 1|Homo sapiens (9606) LDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAEVPTAHPSPSPRPAGQFQTLENLYFQ |
Interaction
1、Solvent accessible surface areas (SASA) were calculated (Naccess V2.1.1) for each residue in antibody and antigen, respectively. The residues with SASA loss in binding of more than 1Å2 were classified as interacting residues.
Interacting residues (ΔSASA based)
| H: TYR52 ASN58 ARG97 TYR99 GLY100 ASN101 TYR102 TRP103 TYR104 ASP106 L: SER30 ASN31 ASP32 ASN49 TYR50 PHE52 HIS53 PHE55 THR56 SER65 GLY66 TYR67 ALA91 TYR92 SER93 SER94 TYR96 P: VAL64 ASN66 TYR68 MET70 SER71 SER73 ASN74 GLN75 THR76 ASP77 LYS78 LEU79 ALA80 ALA81 GLU84 ASP85 ARG86 GLN88 PRO89 GLY90 ASP92 PHE95 ILE126 LEU128 PRO130 LYS131 ALA132 ILE134 GLU136 |
2、We defined interacting paratope-epitope residues by a distance cutoff of < 5Å . Two amino acids are considered as interacting residues if they have at least one atom within a distance of 5 Å from any atom.
Interacting residues (Atom distance based)
